Together, these efforts promise to unravel the complexity of HCFC1-associated epilepsy and advance personalized treatment paradigms for neurodevelopmental disorders linked to transcriptional co-factor dysfunction. This evidence concerns the gene HCFC1 and neurodevelopmental disorder.